Independent. Trusted. Proven.
Expert buy, hold and sell recommendations from our team of analysts.
How can I protect my international shares against a rising Aussie dollar? Is Super Retail Group, which is paying a very attractive dividend, a “buy”? What do the brokers think of Technology One? Does the BOQ dividend reinvestment plan (DRP) issue shares at a discount?
Peter Switzer & Paul Rickard answer your questions on PME, VAS, MQG & more
It’s a good sign that Wall Street was able to finish on a positive note, with all four most-watched indexes (i.e. the Dow, S&P 500, Nasdaq and Russell 2000) all ending up over 1%
Here’s an undervalued Listed Investment Company (LIC) to consider, and another idea for the watchlist.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says that with China banning the exports of rare earths to the US, Lynas Rare Earths (LYC) is a buy again.
Why is the rout in US Treasury Bonds impacting world markets? Why does RIO publish a quarterly production report? Do the brokers see more upside with MediBank Private? With oil stocks being slammed, is Woodside or Santos better value?
Peter Switzer & Paul Rickard answer your questions on AD8, TWE, BHP & more
You never want a serious crisis to go to waste so let me tell you the six quality stocks I’ll be buying as soon as I think ‘normalcy’ is back.
Let’s check out Spark New Zealand (SPK) and APA Group to determine if these two stocks are in the buy zone or should be dropped.
In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.